Lupin says USFDA issues three observations for its Pithampur facility

Lupin Share Price | The USFDA inspected the facility from September 16 to September 27. The pharma company said it is addressing the observations comprehensively and will respond to the US drug regulator within the stipulated timeframe.

Leave a Reply

Your email address will not be published. Required fields are marked *